First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?

Detalhes bibliográficos
Autor(a) principal: Eça, Tiago Fuzeta
Data de Publicação: 2019
Outros Autores: Duarte, Catarina, Levy, João, Ferrão, Otília, Luís, Leonel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.25754/pjp.2019.14920
Resumo:  Introduction: AOM is the most common diagnosis for the prescription of antibiotics in children. The Portuguese National Health Autority issued a clinical guideline in 2012, updated in 2014, in which it recommends the use of amoxicillin as first-line antibiotic. The option is based on the fact that amoxicillin is the most effective oral antibiotic against the microorganisms with the greatest risk for acute invasive disease, Streptococcus pneumoniae. Material and Methods: Between July 1st and December 31st 2016, we e-mailed a number of Pediatricians, Family Physicians and Otolaringologists a clinical case of AOM in a child, giving five options of antibiotherapy. We analised the results. Results: We attained 240 answers, 3 eliminated due to computer error. 102 FP (47 specialists), 74 ENT (33 specialists) and 61 Pediatricians (28 specialists). 96,7% of Pediatricians (CI 95%; 100-84,2%; n=58), 77,8% of FP (CI 95% 87,4-68,2%, n=78) and 32,4% of ENT (CI 95% 43,1-21,7%; N=24) prescribe amoxicillin as first line antibiotic. The prescription of amoxicillin is statistically different between ENT and FP (p<0.02) and between ENT and Pediatrics (p<0.01). Discussion and Conclusion: There are significant differences between specialties concerning the choice for amoxicillin as first line antibiotic. Pediatricians came close to 100% and ENT chose otherwise, preferring Amoxicilin with Clavulanate. This difference may be explained by the bias introduced by the specialty itself (ENT), which generally treats the most complicated cases or the ones resistant to first-line therapy. Key-words: acute otitis media; antibiotherapy; amoxicilin;
id RCAP_fca3ef848bdd0bf631818880b001b613
oai_identifier_str oai:ojs.revistas.rcaap.pt:article/14920
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?Original articles Introduction: AOM is the most common diagnosis for the prescription of antibiotics in children. The Portuguese National Health Autority issued a clinical guideline in 2012, updated in 2014, in which it recommends the use of amoxicillin as first-line antibiotic. The option is based on the fact that amoxicillin is the most effective oral antibiotic against the microorganisms with the greatest risk for acute invasive disease, Streptococcus pneumoniae. Material and Methods: Between July 1st and December 31st 2016, we e-mailed a number of Pediatricians, Family Physicians and Otolaringologists a clinical case of AOM in a child, giving five options of antibiotherapy. We analised the results. Results: We attained 240 answers, 3 eliminated due to computer error. 102 FP (47 specialists), 74 ENT (33 specialists) and 61 Pediatricians (28 specialists). 96,7% of Pediatricians (CI 95%; 100-84,2%; n=58), 77,8% of FP (CI 95% 87,4-68,2%, n=78) and 32,4% of ENT (CI 95% 43,1-21,7%; N=24) prescribe amoxicillin as first line antibiotic. The prescription of amoxicillin is statistically different between ENT and FP (p<0.02) and between ENT and Pediatrics (p<0.01). Discussion and Conclusion: There are significant differences between specialties concerning the choice for amoxicillin as first line antibiotic. Pediatricians came close to 100% and ENT chose otherwise, preferring Amoxicilin with Clavulanate. This difference may be explained by the bias introduced by the specialty itself (ENT), which generally treats the most complicated cases or the ones resistant to first-line therapy. Key-words: acute otitis media; antibiotherapy; amoxicilin;Introdução: A OMA é a razão mais frequente de prescrição de antibiótico em idade pediátrica. A Direção Geral de Saúde elaborou uma Norma de Orientação Clínica em 2012, atualizada em 2014, onde recomenda a utilização de amoxicilina como antibiótico de primeira linha. A opção fundamenta-se no facto da amoxicilina ser o antimicrobiano oral mais eficaz contra o microorganismo com maior risco de doença aguda invasiva, o Streptococcus pneumoniae. Material e métodos: Entre 1 Julho e 31 Dezembro de 2016 enviámos por e-mail, a um número de médicos de MGF, ORL e Pediatria, um caso fictício de OMA em idade pediátrica, dando a escolher cinco opções de antibioterapia. Fizemos o estudo estatístico das respostas. Resultados: Obtivemos 240 respostas, três eliminadas por erro informático. 102 de MGF (47 especialistas), 74 de ORL (33 especialistas) e 61 de Pediatras (28 especialistas). 96,7% dos Pediatras (IC 95%; 84,2-100%; n=58), 77,8% dos MGF (IC 95% 68,2-87,4%, n=78) e 32,4% dos ORL (IC 95% 21,7-43,1%; N=24) prescrevem amoxicilina como antibiótico de primeira linha. A prescrição de amoxicilina é significativamente diferente entre ORL e MGF (p<0,02) e entre ORL e Pediatras (p<0.01). Discussão e Conclusão: Há diferença estatisticamente significativa na escolha da amoxicilina como primeira linha no tratamento da OMA. Os Pediatras aproximam-se dos 100% e os Otorrinolaringologistas afastam-se mais dessa opção, e favorecem a Amoxicilina+Clavulanato. Esta divergência pode ser explicada pelo viés que é introduzido pela própria Especialidade ORL, que geralmente tem que tratar os casos de otite complicados ou refratários à terapêutica de primeira linha. Palavras-Chave: otite média aguda; antibioterapia; amoxicilina;Sociedade Portuguesa de Pediatria2019-04-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.25754/pjp.2019.14920eng2184-44532184-3333Eça, Tiago FuzetaDuarte, CatarinaLevy, JoãoFerrão, OtíliaLuís, Leonelinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-03T02:57:55Zoai:ojs.revistas.rcaap.pt:article/14920Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:25:29.748251Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
title First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
spellingShingle First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
Eça, Tiago Fuzeta
Original articles
title_short First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
title_full First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
title_fullStr First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
title_full_unstemmed First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
title_sort First Line Antibiotics in Acute Otitis Media: Are There Differences Between Specialties?
author Eça, Tiago Fuzeta
author_facet Eça, Tiago Fuzeta
Duarte, Catarina
Levy, João
Ferrão, Otília
Luís, Leonel
author_role author
author2 Duarte, Catarina
Levy, João
Ferrão, Otília
Luís, Leonel
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Eça, Tiago Fuzeta
Duarte, Catarina
Levy, João
Ferrão, Otília
Luís, Leonel
dc.subject.por.fl_str_mv Original articles
topic Original articles
description  Introduction: AOM is the most common diagnosis for the prescription of antibiotics in children. The Portuguese National Health Autority issued a clinical guideline in 2012, updated in 2014, in which it recommends the use of amoxicillin as first-line antibiotic. The option is based on the fact that amoxicillin is the most effective oral antibiotic against the microorganisms with the greatest risk for acute invasive disease, Streptococcus pneumoniae. Material and Methods: Between July 1st and December 31st 2016, we e-mailed a number of Pediatricians, Family Physicians and Otolaringologists a clinical case of AOM in a child, giving five options of antibiotherapy. We analised the results. Results: We attained 240 answers, 3 eliminated due to computer error. 102 FP (47 specialists), 74 ENT (33 specialists) and 61 Pediatricians (28 specialists). 96,7% of Pediatricians (CI 95%; 100-84,2%; n=58), 77,8% of FP (CI 95% 87,4-68,2%, n=78) and 32,4% of ENT (CI 95% 43,1-21,7%; N=24) prescribe amoxicillin as first line antibiotic. The prescription of amoxicillin is statistically different between ENT and FP (p<0.02) and between ENT and Pediatrics (p<0.01). Discussion and Conclusion: There are significant differences between specialties concerning the choice for amoxicillin as first line antibiotic. Pediatricians came close to 100% and ENT chose otherwise, preferring Amoxicilin with Clavulanate. This difference may be explained by the bias introduced by the specialty itself (ENT), which generally treats the most complicated cases or the ones resistant to first-line therapy. Key-words: acute otitis media; antibiotherapy; amoxicilin;
publishDate 2019
dc.date.none.fl_str_mv 2019-04-29
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.25754/pjp.2019.14920
url https://doi.org/10.25754/pjp.2019.14920
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2184-4453
2184-3333
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Pediatria
publisher.none.fl_str_mv Sociedade Portuguesa de Pediatria
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133524283883520